Today: 19 April 2026
Australian Securities Exchange Weekly Wrap: ASX 200 Sheds A$130 Billion as Middle East War and Rate Risks Rattle Stocks
7 March 2026
1 min read

Australian Securities Exchange Weekly Wrap: ASX 200 Sheds A$130 Billion as Middle East War and Rate Risks Rattle Stocks

SYDNEY, March 7, 2026, 17:47 AEDT

Australian stocks took a hard hit last week, with the S&P/ASX 200 tumbling 3.8% amid escalating concerns over the Middle East conflict. Investors saw around A$130 billion ($91.4 billion) in value erased from the market. On Friday, the index sank another 1%, which wiped out close to half the gains made in February.

The timing is critical, as the selloff comes up against a more hawkish domestic rates backdrop. Reserve Bank of Australia Governor Michele Bullock called March 17 a “live meeting,” just as new data revealed fourth-quarter GDP up 0.8% and annual growth at 2.6%—both quicker than anticipated. Reuters

It was a staggered slide this week. The ASX dropped 1.34% Tuesday, followed by a 1.94% loss Wednesday, daily summaries showed. Thursday’s small 0.4% rebound barely registered before Friday took the index down another 1%, according to Reuters.

Miners took the brunt of the losses by Friday. Local miners slid 4.1%, gold miners were down 4.3%. Financials slipped 0.5%. Energy names managed a slight gain, climbing 0.2% as oil kept rising.

The split came after a tough earnings stretch. Commonwealth Bank jumped up to 8.4% in February, powered by record first-half cash earnings, while BHP surged 7% to an all-time high on a bigger-than-forecast dividend. CSL, though, slumped, sliding after posting an 81% plunge in first-half profit.

Nick Twidale at ATFX Global doesn’t mince words: “Global downturns always hit Australia harder,” he said, flagging the risk of a “real downturn” if the conflict drags out. Atlas Funds Management’s Phil Cornet echoed concerns, noting that a sustained war could batter asset prices worldwide. Meanwhile, JPMorgan strategists headed by Jason Steed called February a “record” month for sharp, single-day swings in ASX stocks. Reuters

The risk here is pretty clear. Bullock has already flagged that if energy prices keep climbing, consumers and growth will feel the pain, and inflation gets an extra push. Reuters’ global markets desk pointed out Brent jumped over 20% and U.S. crude surged 25% on the week, with the Strait of Hormuz tensions worsening. That combination can easily lock in high borrowing costs, even if sentiment keeps sliding.

There’s another route. Thursday’s short-lived bounce made clear just how fast sentiment shifts when diplomacy with Iran is even mentioned. Consumers remain wary, and with the RBA set for March 17, traders are heading into the week focused on oil, war news, and rate moves, rather than what companies are saying.

Stock Market Today

  • Humana (HUM) Valuation Highlights Volatility and Future Growth Potential
    April 19, 2026, 5:44 AM EDT. Humana (ticker: HUM) has seen volatile share price movements recently, with a 21% gain over one month contrasting a 25% decline over three months. The stock trades at $205.14, slightly below its narrative fair value of $212.87, suggesting it may be undervalued. Analysts highlight Medicare Advantage expansion as a key growth driver, emphasizing that robust compliance and data-driven operations will be critical for sustained profitability. Total shareholder returns over one year and three years stand at 21% and 57%, respectively. Investors face risks including potential tightening of Medicare scrutiny and rising compliance costs, which could pressure margins. The balance of risk and reward warrants careful consideration for portfolio positioning in the healthcare sector.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 19.04.2026

19 April 2026
LIVEMarkets rolling coverageStarted: April 19, 2026, 12:00 AM EDTUpdated: April 19, 2026, 5:46 AM EDT Humana (HUM) Valuation Highlights Volatility and Future Growth Potential April 19, 2026, 5:44 AM EDT. Humana (ticker: HUM) has seen volatile share price movements recently, with a 21% gain over one month contrasting a 25% decline over three months. The stock trades at $205.14, slightly below its narrative fair value of $212.87, suggesting it may be undervalued. Analysts highlight Medicare Advantage expansion as a key growth driver, emphasizing that robust compliance and data-driven operations will be critical for sustained profitability. Total shareholder returns over one
Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
Taiwan stocks’ wild week: TAIEX posts sharp loss as war-driven oil shock batters chip bellwethers
Previous Story

Taiwan stocks’ wild week: TAIEX posts sharp loss as war-driven oil shock batters chip bellwethers

Korea Exchange Last Week: KOSPI Ends Down 11% After Record Crash, KOSDAQ Limits Damage
Next Story

Korea Exchange Last Week: KOSPI Ends Down 11% After Record Crash, KOSDAQ Limits Damage

Go toTop